Trials / Completed
CompletedNCT04757935
Yoga for Youth With IBD: a Pilot Feasibility Study
The Effects of Yoga on Disease Activity in Youth With Inflammatory Bowel Disease: a Pilot Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 10 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
An 8-week yoga intervention to determine the feasibility and acceptability of yoga as a supplemental therapy in the management of inflammatory bowel disease in the adolescent population.
Detailed description
Youth with IBD experience abdominal pain, diarrhea, weight loss, and psychological suffering related to their disease process. While many biologic and non-biologic therapies are available to target the inflammatory component of IBD, youth with IBD could benefit from a more holistic therapy that addresses psychological wellness, which has been shown, in turn, to reduce disease burden. It is known that stress (multiple varieties) leads to IBD flares. It is also known that mind-body intervention reduces stress. The mind-gut connection is widely discussed in medical circles, however, current therapies have not capitalized on it. The investigators would like to know if an easily accessible mind-body intervention (yoga) can improve wellness, lower stress levels, and reduce intestinal inflammation in youth with IBD. The study will be an 8-week feasibility pilot. Participants will be asked to participate in online yoga videos and in-studio yoga sessions. Participants will be asked to complete multiple surveys throughout the intervention and continue receiving standard care from their primary gastroenterology team.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Yoga | Yoga for 30 minutes three times weekly for 8 weeks in addition to three, 1-hour in-studio yoga sessions. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-05-31
- Completion
- 2017-05-31
- First posted
- 2021-02-17
- Last updated
- 2021-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04757935. Inclusion in this directory is not an endorsement.